Cargando…

The ferroptosis-related long non-coding RNAs signature predicts biochemical recurrence and immune cell infiltration in prostate cancer

BACKGROUND: Findings from numerous studies have revealed that ferroptosis is closely related to tumorigenesis and immune cell infiltration. Long non-coding RNAs (lncRNAs) are reportedly involved in the progression of various cancers, including prostate cancer (PCa). This study was designed to establ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chunhui, Gao, Yue, Ni, Jiaxuan, Chen, Saisai, Hu, Qiang, Wang, Can, Hu, Mingjin, Chen, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290257/ https://www.ncbi.nlm.nih.gov/pubmed/35850679 http://dx.doi.org/10.1186/s12885-022-09876-8

Ejemplares similares

Identifying a Ferroptosis-Related Gene Signature for Predicting Biochemical Recurrence of Prostate Cancer
por: Lv, Zhengtong, et al.
Publicado: (2021)

Identification of seven long noncoding RNAs signature for prediction of biochemical recurrence in prostate cancer
por: Shao, Ning, et al.
Publicado: (2019)

A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer
por: Ke, Zhi-Bin, et al.
Publicado: (2022)

Identification of a Ferroptosis-Related Signature Associated with Prognosis and Immune Infiltration in Adrenocortical Carcinoma
por: Chen, Xi, et al.
Publicado: (2021)

Development and Validation of Ferroptosis- and Immune-Related lncRNAs Signatures for Breast Infiltrating Duct and Lobular Carcinoma
por: Wei, Tao, et al.
Publicado: (2022)

Role of ferroptosis and ferroptosis-related non-coding RNAs in the occurrence and development of gastric cancer
por: Lu, Ling, et al.
Publicado: (2022)

High expression of Rab25 contributes to malignant phenotypes and biochemical recurrence in patients with prostate cancer after radical prostatectomy
por: Hu, Chunhui, et al.
Publicado: (2017)

Transcriptome analysis reveals a long non-coding RNA signature to improve biochemical recurrence prediction in prostate cancer
por: Xu, Jinyuan, et al.
Publicado: (2018)

Integration of transcriptomics reveals ferroptosis-related signatures and immune cell infiltration in bronchopulmonary dysplasia
por: Hu, Zhengyun, et al.
Publicado: (2023)

Identification of a novel senescence-associated signature to predict biochemical recurrence and immune microenvironment for prostate cancer
por: Han, Chenglin, et al.
Publicado: (2023)

Identification of the Ferroptosis-Related Long Non-Coding RNAs Signature to Improve the Prognosis Prediction in Papillary Renal Cell Carcinoma
por: Tang, Xinfang, et al.
Publicado: (2022)

Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC
por: Li, Meng, et al.
Publicado: (2021)

Non-coding RNAs in necroptosis, pyroptosis and ferroptosis in cancer metastasis
por: Liu, Yan, et al.
Publicado: (2021)

Non-coding RNAs in necroptosis, pyroptosis, and ferroptosis in cardiovascular diseases
por: Cai, Yuxi, et al.
Publicado: (2022)

5-Methylcytosine RNA Methyltransferases-Related Long Non-coding RNA to Develop and Validate Biochemical Recurrence Signature in Prostate Cancer
por: Wang, Ke, et al.
Publicado: (2021)

Circulating microRNAs predict biochemical recurrence in prostate cancer patients
por: Selth, L A, et al.
Publicado: (2013)

Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma
por: Chen, Xinyi, et al.
Publicado: (2022)

Gene signatures predict biochemical recurrence‐free survival in primary prostate cancer patients after radical therapy
por: Su, Qiang, et al.
Publicado: (2021)

Correction: Non-coding RNAs in necroptosis, pyroptosis and ferroptosis in cancer metastasis
por: Liu, Yan, et al.
Publicado: (2021)

An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma
por: Li, Gen, et al.
Publicado: (2022)

Regulation of ferroptosis by non-coding RNAs in the development and treatment of cancer
por: Luo, Yajun, et al.
Publicado: (2021)

Regulation of Ferroptosis by Non-Coding RNAs in Head and Neck Cancers
por: Hsieh, Pei-Ling, et al.
Publicado: (2022)

Non-coding RNAs and ferroptosis: potential implications for cancer therapy
por: Balihodzic, Amar, et al.
Publicado: (2022)

A new ferroptosis-related signature model including messenger RNAs and long non-coding RNAs predicts the prognosis of gastric cancer patients
por: Liu, Yang, et al.
Publicado: (2023)

A Novel Angiogenesis-Related Gene Signature to Predict Biochemical Recurrence of Patients with Prostate Cancer following Radical Therapy
por: Fan, Bohan, et al.
Publicado: (2022)

Multiphoton Microscopy for Identifying Collagen Signatures Associated with Biochemical Recurrence in Prostate Cancer Patients
por: Pavlova, Ina P., et al.
Publicado: (2021)

Immune infiltration and a ferroptosis-associated gene signature for predicting the prognosis of patients with endometrial cancer
por: Weijiao, Yin, et al.
Publicado: (2021)

Construction of prognostic signature of patients with oral squamous cell carcinoma based on pyroptosis-related long non-coding RNAs
por: Xin, Yuqi, et al.
Publicado: (2022)

Ferroptosis-Related Gene Signature and Patterns of Immune Infiltration Predict the Overall Survival in Patients With Lung Adenocarcinoma
por: Wang, Yuxuan, et al.
Publicado: (2021)

Mechanisms of long non-coding RNAs in biological phenotypes and ferroptosis of glioma
por: Yin, Xianyong, et al.
Publicado: (2022)

Identification of hub ferroptosis-related genes and immune infiltration in lupus nephritis using bioinformatics
por: Hu, Weitao, et al.
Publicado: (2022)

Ferroptosis-Related Gene Signature Promotes Ovarian Cancer by Influencing Immune Infiltration and Invasion
por: You, Yang, et al.
Publicado: (2021)

A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer
por: Lu, Jianming, et al.
Publicado: (2023)

An Immune-Related lncRNA Signature to Predict the Biochemical Recurrence and Immune Landscape in Prostate Cancer
por: Zhang, Guian, et al.
Publicado: (2021)

A Novel Four Mitochondrial Respiration-Related Signature for Predicting Biochemical Recurrence of Prostate Cancer
por: Xia, Zhongyou, et al.
Publicado: (2023)

Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma
por: Liang, Jiaying, et al.
Publicado: (2021)

Bioinformatic Analyses of the Ferroptosis-Related lncRNAs Signature for Ovarian Cancer
por: Zheng, Jianfeng, et al.
Publicado: (2022)

Construction of a Ferroptosis-Related Long Non-coding RNA Prognostic Signature and Competing Endogenous RNA Network in Lung Adenocarcinoma
por: Fei, Xiang, et al.
Publicado: (2021)

A ferroptosis-related gene signature for overall survival prediction and immune infiltration in lung squamous cell carcinoma
por: Miao, Ti-wei, et al.
Publicado: (2022)

Immune signature driven by ADT-induced immune microenvironment remodeling in prostate cancer is correlated with recurrence-free survival and immune infiltration
por: Long, Xingbo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5li64q9l8skhfpo89sbhgh3f7i